Dupont Capital Management Corp Collegium Pharmaceutical, Inc Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$17.2 - $22.5 $12,108 - $15,840	-704 Reduced 8.13%	7,951 $162,000
Q4 2021 Jan 31, 2022	SELL	$17.5 - $21.35 $60,410 - $73,700	-3,452 Reduced 28.51%	8,655 $162,000
Q3 2021 Nov 03, 2021	SELL	$17.75 - $25.39 $30,388 - $43,467	-1,712 Reduced 12.39%	12,107 $239,000
Q1 2021 Apr 29, 2021	SELL	$19.25 - $26.1 $54,554 - $73,967	-2,834 Reduced 17.02%	13,819 $328,000
Q4 2020 Jan 28, 2021	SELL	$17.83 - $22.29 $22,162 - $27,706	-1,243 Reduced 6.95%	16,653 $334,000
Q3 2020 Oct 29, 2020	BUY	$15.78 - $20.82 $93,322 - $123,129	5,914 Added 49.36%	17,896 $373,000
Q2 2020 Jul 24, 2020	SELL	$15.49 - $23.51 $106,152 - $161,114	-6,853 Reduced 36.38%	11,982 $210,000
Q1 2020 Apr 29, 2020	BUY	$13.89 - $25.45 $261,618 - $479,350	18,835 New	18,835 $308,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.